Pharma News
-
NBQ moves ahead with transformative treatment for brain cancers
Pharma | News | 0 Comment | 24 Jul, 2020
A Chinese clinical-stage biopharmaceutical company, N.B. Quadriga (NBQ), developing transformative medicines for brain c...Read more
-
Hansoh announces strategic collaboration with EQRx for almonertinib
Pharma | News | 0 Comment | 24 Jul, 2020
Shanghai-based Hansoh Pharmaceutical Group Company Ltd., a leading biopharmaceutical company has recently announced a st...Read more
-
ACT Sustainability Certification for Eppendorf ULT freezers
Pharma | News | 0 Comment | 24 Jul, 2020
The Eppendorf ULT freezers are the first freezers worldwide being validated by My Green Lab: The CryoCube® F5...Read more
-
US inks $1.95B deal with Pfizer, BioNTech for COVID-19 vaccine doses
Pharma | News | 0 Comment | 24 Jul, 2020
Pfizer Inc. and BioNTech SE have announced the execution of an agreement with the U.S. Department of Health and Human Se...Read more
-
Ascentage Pharma doses first patient with APG-115
Pharma | News | 0 Comment | 23 Jul, 2020
Ascentage Pharma, a globally focused biotechnology company engaged in developing novel therapies for cancers, chronic he...Read more
-
Daiichi Sankyo & Gustave Roussy collaborate for oncology research
Pharma | News | 0 Comment | 23 Jul, 2020
Tokyo based Daiichi Sankyo Company Ltd. and France based Gustave Roussy recently announced a multi-year, multi-study res...Read more
-
Biocon presents Clinical results for DCGI approval of Itolizumab for COVID-19
Pharma | News | 0 Comment | 13 Jul, 2020
India’s Biocon Ltd., an innovation-led global biopharmaceuticals company, on 13 July 2020 presented key insights i...Read more
-
Fujitsu established new company "Fujitsu Japan Ltd."
Pharma | News | 0 Comment | 17 Jul, 2020
On 17 July 2020, Fujitsu announced the establishment of its new company "Fujitsu Japan Ltd." on October 1...Read more
-
Malaysia approves new early breast cancer drug
Pharma | News | 0 Comment | 20 Jul, 2020
A NEW breast cancer drug NERLYNX® (neratinib) shown to significantly reduce the risk of cancer recurrence is no...Read more
-
ISPE releases "ISPE Good Practice Guide: Critical Utilities GMP Compliance" guide
Pharma | News | 0 Comment | 16 Jul, 2020
The International Society for Pharmaceutical Engineering (ISPE) announced the release of its latest guide,&nbs...Read more
-
Ovid Therapeutics, Angelini to produce Angelman syndrome treatment
Pharma | News | 0 Comment | 16 Jul, 2020
Ovid Therapeutics Inc., a biopharmaceutical company committed to developing medicines that transform the lives of people...Read more
-
Daiichi Sankyo announces participation in AMR action fund
Pharma | News | 0 Comment | 17 Jul, 2020
Japanese firm Daiichi Sankyo Company, Limited has announced its decision to participate in the Antimicrobial Resistance ...Read more
-
Pharma | News | 0 Comment | 13 Jul, 2020
The International Society for Pharmaceutical Engineering (ISPE) announced today the formation of the new ...Read more
-
Clinuvel launches second afamelanotide formulation
Pharma | News | 0 Comment | 15 Jul, 2020
Australia based CLINUVEL Pharmaceuticals, has announced PRÉNUMBRA®, the Company’s second afamelanotide ...Read more
-
Eisai enters industry-academia-government joint research agreement
Pharma | News | 0 Comment | 15 Jul, 2020
Japanese firm Eisai Co., Ltd. announced that it has entered into an industry-academia-government joint research agreemen...Read more
-
Pfizer, BioNTech to manufacture up to 100 M doses by 2020 end
Pharma | News | 0 Comment | 14 Jul, 2020
Pfizer Inc. and BioNTech SE have announced that two of the companies’ four investigational vaccine candi...Read more
-
Carromex unveils leads for rapid drug analysis and discovery
Pharma | News | 0 Comment | 13 Jul, 2020
Carromex, a mathematical research-based innovation company based in Australia, unveiled a new cloud-based pharmaceu...Read more
-
Chemopharm ramps up efforts to fight COVID-19
Pharma | News | 0 Comment | 10 Jul, 2020
Chemopharm Sdn Bhd has become the first company in Malaysia to partner with Standard Chartered as part of the Bank&rsquo...Read more
